Overview

Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

Status:
Completed
Trial end date:
2010-02-19
Target enrollment:
Participant gender:
Summary
Phase 2 study to examine how the study drug works and its side effects in subjects with toenail fungus.
Phase:
Phase 2
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Albaconazole